药物发现与开发中基于生理的药代动力学建模的基本概念。 - Suppr

Suppr

超能文献

Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.

作者信息

Jones Hm, Rowland-Yeo K

机构信息

Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2013 Aug 14;2(8):e63. doi: 10.1038/psp.2013.41.

DOI:10.1038/psp.2013.41

PMID:23945604

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3828005/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064b/3828005/2287641a80e0/psp201341f1.jpg

相似文献

Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.药物发现与开发中基于生理的药代动力学建模的基本概念。

CPT Pharmacometrics Syst Pharmacol. 2013 Aug 14;2(8):e63. doi: 10.1038/psp.2013.41.

State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.儿科药物开发中基于生理的药代动力学建模的最新技术综述。

Clin Pharmacokinet. 2019 Jan;58(1):1-13. doi: 10.1007/s40262-018-0677-y.

Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.药物发现与开发中基于生理学的药代动力学建模：制药行业视角

Clin Pharmacol Ther. 2015 Mar;97(3):247-62. doi: 10.1002/cpt.37. Epub 2015 Jan 9.

Evolving role of modeling and simulation in drug development.建模与模拟在药物研发中的角色演变

Transl Clin Pharmacol. 2019 Mar;27(1):19-23. doi: 10.12793/tcp.2019.27.1.19. Epub 2019 Mar 27.

Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.基于生理的药代动力学模型在优化抗感染治疗中的应用。

Expert Opin Drug Metab Toxicol. 2015;11(8):1203-17. doi: 10.1517/17425255.2015.1037278. Epub 2015 Apr 15.

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of Clinical Studies: Current Status, Challenges, and Opportunities.基于生理学的药代动力学/药效动力学模型在支持临床研究豁免中的应用：现状、挑战和机遇。

Mol Pharm. 2021 Jan 4;18(1):1-17. doi: 10.1021/acs.molpharmaceut.0c00903. Epub 2020 Dec 15.

Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.应用基于生理学的药代动力学模型评估药物相互作用。

Future Med Chem. 2012 Apr;4(5):681-93. doi: 10.4155/fmc.12.13.

Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.基于生理的药代动力学建模工具的开发与应用以支持药物发现。

Chem Biodivers. 2005 Nov;2(11):1462-86. doi: 10.1002/cbdv.200590119.

Impact of physiologically based pharmacokinetic modeling and simulation in drug development.生理药代动力学建模和模拟在药物研发中的影响。

Drug Metab Dispos. 2013 Dec;41(12):1994-2003. doi: 10.1124/dmd.113.052803. Epub 2013 Sep 5.

Physiologically Based Pharmacokinetic Modeling of Therapeutic Proteins.治疗性蛋白质的生理药代动力学建模

J Pharm Sci. 2017 Sep;106(9):2270-2275. doi: 10.1016/j.xphs.2017.03.038. Epub 2017 Apr 7.

引用本文的文献

In Silico ADME Methods Used in the Evaluation of Natural Products.用于天然产物评估的计算机辅助ADME方法

Pharmaceutics. 2025 Jul 31;17(8):1002. doi: 10.3390/pharmaceutics17081002.

Application of Physiologically-Based Pharmacokinetic (PBPK) Model in Drug Development and in Dietary Phytochemicals.基于生理的药代动力学（PBPK）模型在药物研发及膳食植物化学物中的应用

Curr Pharmacol Rep. 2025;11(1):45. doi: 10.1007/s40495-025-00427-w. Epub 2025 Aug 8.

Tailoring oral targeted therapies dosage in lung cancer: A systematic review of pharmacokinetics studies on renal and hepatic impairment.肺癌口服靶向治疗药物剂量调整：关于肾和肝损伤的药代动力学研究的系统评价

PLoS One. 2025 Jul 29;20(7):e0324056. doi: 10.1371/journal.pone.0324056. eCollection 2025.

Development of a Multi-Purpose Comprehensive Physiologically Based Pharmacokinetic Model for Crizotinib: An Example Application in Bioequivalence Assessment between Oral Solution and Granules in Pediatric Subjects.克唑替尼多用途综合生理药代动力学模型的开发：儿科受试者口服溶液与颗粒剂生物等效性评估的示例应用

AAPS J. 2025 Jul 28;27(5):126. doi: 10.1208/s12248-025-01106-w.

Enhancing therapeutic strategies and drug development for patients with kidney disease.改善肾病患者的治疗策略与药物研发。

Expert Opin Drug Saf. 2025 Jul 4:1-26. doi: 10.1080/14740338.2025.2525970.

Physiologically Based Pharmacokinetic Modeling of Antibiotics in Children: Perspectives on Model-Informed Precision Dosing.儿童抗生素的生理药代动力学建模：模型指导精准给药的观点

Antibiotics (Basel). 2025 May 24;14(6):541. doi: 10.3390/antibiotics14060541.

Accelerating Biologics PBPK Modelling with Automated Model Building: A Tutorial.通过自动模型构建加速生物制品的生理药代动力学（PBPK）建模：教程

Pharmaceutics. 2025 May 2;17(5):604. doi: 10.3390/pharmaceutics17050604.

Extension and validation of a physiologically based toxicokinetic model for risk assessment of aluminium exposure in humans.用于人体铝暴露风险评估的基于生理学的毒代动力学模型的扩展与验证

Arch Toxicol. 2025 Jun;99(6):2379-2395. doi: 10.1007/s00204-025-04031-1. Epub 2025 Apr 19.

Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry.使用基于生理药代动力学模型的反向剂量测定法对运动前补充剂成分的人肾上腺素能和痕量胺相关受体1效价进行体外到体内的定量外推。

Arch Toxicol. 2025 May;99(5):1999-2021. doi: 10.1007/s00204-025-03992-7. Epub 2025 Apr 3.

Information-theoretic evaluation of covariate distributions models.协变量分布模型的信息论评估

J Pharmacokinet Pharmacodyn. 2025 Mar 27;52(2):21. doi: 10.1007/s10928-025-09968-5.

本文引用的文献

The utility of modeling and simulation in drug development and regulatory review.建模和模拟在药物研发和监管审查中的应用。

J Pharm Sci. 2013 Sep;102(9):2912-23. doi: 10.1002/jps.23570. Epub 2013 May 24.

Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?系统药理学在药物发现和开发中的应用：范式转变还是昙花一现？

Clin Pharmacol Ther. 2013 May;93(5):379-81. doi: 10.1038/clpt.2013.40.

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions.生理药代动力学建模和模拟在解决临床药理学监管问题方面的最佳实践。

Clin Pharmacol Ther. 2012 Jul;92(1):17-20. doi: 10.1038/clpt.2012.68.

A novel relay method for determining low-clearance values.一种确定低间隙值的新型继电器方法。

Drug Metab Dispos. 2012 Sep;40(9):1860-5. doi: 10.1124/dmd.112.046425. Epub 2012 May 29.

Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.基于生理学的药代动力学与 ADME 的体外-体内外推相结合：系统药理学拱门下的联姻。

Clin Pharmacol Ther. 2012 Jul;92(1):50-61. doi: 10.1038/clpt.2012.65. Epub 2012 May 30.

Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.基于生理学的普伐他汀转运体介导的肝胆处置和药物相互作用的建模。

Pharm Res. 2012 Oct;29(10):2860-73. doi: 10.1007/s11095-012-0792-7. Epub 2012 May 26.

Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.正常妊娠期间与妊娠龄相关的解剖学、生理学和代谢变化：用于生理基于药代动力学建模的所需参数的数据库。

Clin Pharmacokinet. 2012 Jun 1;51(6):365-96. doi: 10.2165/11597440-000000000-00000.

Predicting drug interaction potential with a physiologically based pharmacokinetic model: a case study of telithromycin, a time-dependent CYP3A inhibitor.运用基于生理学的药代动力学模型预测药物相互作用的可能性：以时间依赖性 CYP3A 抑制剂泰利霉素为例的一项案例研究。

Clin Pharmacol Ther. 2012 Apr;91(4):700-8. doi: 10.1038/clpt.2011.305. Epub 2012 Mar 7.

From preclinical to human--prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example.从临床前到人体——在工业环境中使用基于生理学的药代动力学（PBPK）建模方法预测口服吸收和药物相互作用潜力：使用案例的工作流程。

Biopharm Drug Dispos. 2012 Mar;33(2):111-21. doi: 10.1002/bdd.1782.

Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.基于人肝 sandwich 培养物肝细胞数据的转运体介导处置的机制药代动力学建模以用于在人体中的预测。

Drug Metab Dispos. 2012 May;40(5):1007-17. doi: 10.1124/dmd.111.042994. Epub 2012 Feb 16.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验